Recent advances in molecular pathophysiology in diffuse large B-cell lymphoma and high-grade B-cell lymphoma

DOI Web Site PubMed
  • ENNISHI Daisuke
    Center for Comprehensive Genomic Medicine, Okayama University Hospital

Bibliographic Information

Other Title
  • DLBCLとhigh-grade B-cell lymphomaの分子病態に関わる最近の知見
  • DLBCL ト high-grade B-cell lymphoma ノ ブンシ ビョウタイ ニ カカワル サイキン ノ チケン

Search this article

Abstract

<p>Diffuse large B-cell lymphoma (DLBCL) represents a largest number of entities among lymphoid cancers, which are an aggregate of clinically and biologically diverse diseases. In particular, it is believed that various molecular genetic abnormalities are involved in the tumorigenesis of disease development. Owing to recent developments in multiomics analyses, gene expression profile reflecting cell-of-origin and tumor microenvironment and recurrent genetic abnormalities have been discovered; this is an important aspect for the development of future new therapeutic drugs and indications for clinical trials, ultimately encouraging precision medicine in the area of DLBCL. Here, we discuss the possibility of patient stratification based on genetic abnormality.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 62 (6), 624-630, 2021

    The Japanese Society of Hematology

Keywords

Details 詳細情報について

Report a problem

Back to top